We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




Molecular Test Used to Battle West Nile Virus

By LabMedica International staff writers
Posted on 26 Sep 2012
The West Nile Virus (WNV) laboratory test is performed when a person who may have had recent exposure to the virus shows possible signs and symptoms of an infection.

The test is able to confirm whether the infection exists, allowing physicians to take action to control its impact and in severe cases, this might include hospital care where patients can receive supportive treatment including intravenous fluids, help with breathing, and nursing care. More...


Laboratory diagnosis of WNV infections is generally accomplished by testing of serum or cerebrospinal fluid (CSF) to detect virus-specific IgM and neutralizing antibodies. There are four WNV IgM ELISA kits from different manufacturers that are commercially available in the USA and are approved by US Food and Drug Administration (FDA; Silver Springs, MD, USA). In serious or fatal cases, the nucleic acid amplification test (NAAT), histopathology with immunohistochemistry and virus culture of autopsy tissues can also be useful. Only a few state laboratories or other specialized laboratories are capable of doing this specialized testing.

The NAAT technique is used because it measures the WNV’s genetic material, the test can detect an infection before the antibody test. This test is routinely used to screen donated units of blood, as well as donated tissue and organs. It also can be used to test birds and mosquito pools for WNV, often before any people have been identified with the disease, which helps public health experts track the virus’s spread through the community or region. Severe symptoms of WNV can include high fever, headache, neck stiffness, stupor, disorientation, coma, tremors, convulsions, muscle weakness, vision loss, numbness, and paralysis.

A record-breaking 1,590 human cases of WNV have been reported in the USA during 2012, including 65 deaths, according to the US Centers for Disease Control and Prevention (CDC; Atlanta GA, USA). Alan Mertz, MA, the president of the American Clinical Laboratory Association (Washington, DC, USA), said, "The test was developed quickly to respond to WNV when it first appeared in the USA. The test is a good example of the kind of innovative tests that clinical laboratories have discovered quickly in response to new and emerging medical crises, such as human immunodeficiency virus (HIV), herpes meningitis, severe acute respiratory syndrome (SARS), Influenza A subtype H1N1, and Avian flu.”

Related Links:

US Food and Drug Administration

US Centers for Disease Control and Prevention

American Clinical Laboratory Association




Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Verification Panels for Assay Development & QC
Seroconversion Panels
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Real-Time PCR System
Gentier 96T
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.